Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue April 2015
 •  Analysts Poke Holes in Lafley's Strategy  •  Estee Lauder Taps Eva Mendes  •  Scent Trends for 2016  •  Dollar Derails P&G  •  StriVectin Partners with mySkin Inc.
Print

Rhodia’s Novecare Unit Offers Global Solutions



Published March 4, 2008
Related Searches: men hosts latin global
Post a comment
In today’s global market, solutions to difficult formulating problems can rarely be found in one’s own backyard. That’s why Rhodia’s Novecare home and personal care unit has established re- search centers around the globe to help its customers find solutions to all of their formulating problems. At its Center for Research and Technology in Bristol, PA, executives explained how the company is well positioned to meet customers’ needs for hair and skin conditioning, specialty cleansing and home care.

“We’ve got R&D corporate centers (HPC) in the U.S., France, Brazil, Singapore and Shanghai,” explained John Cherkauskas Jr., vice president, R&D for North America. “All together, we’ve built a global team of 41 dedicated scientists and engineers.”

The company even operates a Lab of the Future based in Bordeaux, France, where Rhodia has partnered with the French National Center for Scientific Research. The site hosts research scientists sent on temporary assignments from Rhodia’s worldwide centers, in addition to Ph.D. and post-doc students from universities.

“We have a diverse group of employees with outstanding formulation expertise,” said Rajesh Pazhianur, technical manager, home and personal care. “We can deliver extra benefits unlike any other company.”
This kind of dedication has helped Rhodia roll out an array of novel products and improve financial results as well. And Novecare is one of Rhodia’s growth engines. At press time, 2007 results had not been released, but David Klucsik, director of communications and public affairs, North America, noted that the company is well-positioned to gain market share around the world, especially in emerging markets.

“In 2006, we exceeded all the targets that we had set for ourselves back in 2003,” explained Mr. Klucsik. “Novecare is a big reason for that success.”


blog comments powered by Disqus